MB
Insider
Mark Elliott Boulding
EXEC. VP AND CLOMark Elliott Boulding (EXEC. VP AND CLO) filed 12 Form 4 reports in the trailing twelve months (0 purchases, 12 sales), most often in PTC Therapeutics, Inc. (PTCT). The largest single filing was $1.3M of PTCT (20,390 sh across 5 lots, as filed), executed Oct 3 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
12
0 buys · 12 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$4.2M
shares × price, as filed
Last traded
Aug 17
Filed Aug 19
Median ADV $125.1M across their filed names
Open performance→Volume by month
Buys $0
Sells $16.7M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
12 filings
Sector per market data · by filing · past 12 months
Most traded names
PTCTRecent filings
PTCTSALE
PTC Therapeutics, Inc.
View filing →
$4.9M93,815 sh across 4 lots
Exec Dec 2 2024
Filed Dec 4 2024 · 5:30 PM ET